VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 190 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,086 | -99.7% | 282,268 | +520.3% | 0.12% | +310.7% |
Q4 2019 | $747,000 | +20.7% | 45,507 | -2.4% | 0.03% | +7.7% |
Q3 2019 | $619,000 | -5.9% | 46,623 | -0.2% | 0.03% | 0.0% |
Q2 2019 | $658,000 | -23.8% | 46,733 | -0.3% | 0.03% | -25.7% |
Q1 2019 | $863,000 | -64.9% | 46,877 | -53.3% | 0.04% | -31.4% |
Q4 2018 | $2,461,000 | +113.6% | 100,279 | +99.8% | 0.05% | +15.9% |
Q3 2018 | $1,152,000 | +20.4% | 50,182 | -0.2% | 0.04% | +12.8% |
Q2 2018 | $957,000 | +6.1% | 50,260 | -6.1% | 0.04% | +2.6% |
Q1 2018 | $902,000 | -23.1% | 53,530 | -30.6% | 0.04% | -22.4% |
Q4 2017 | $1,173,000 | -52.7% | 77,160 | -44.3% | 0.05% | -50.5% |
Q3 2017 | $2,478,000 | – | 138,446 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |